remodel trial semaglutide Mechanistic effects of on kidney disease in type 2 diabetes: The trial" by Katherine Tuttle et al, was awarded with ISNWCN Preserving Kidney Health: Top Scored Abstract. Visual abstract by Post hoc analysis of SUSTAIN

Find out How much ozempic should I inject for weight loss

Conclusions Combination of SGLT2i and GLP-1RA achieved significantly better cardiometabolic outcomes compared with SGLT2i alone

Researchers say a genetic test that can help identify a "hungry gut" phenotype can help determine which people will lose the most weight using semaglutide medications such as Wegovy

PlexusDx provides personalized GLP-1 therapy with comprehensive health screening to ensure safe medication combinations

Can Wegovy cause colitis

The first half of 2025 has confirmed a seismic shift in the pharmaceutical landscape: GLP-1 receptor agonists a class of new drug therapies for diabetes